Woburn, MA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today the availability of Javadin™ (clonidine hydrochloride) oral solution, the only FDA-approved, ...
MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...
Woburn, MA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Javadin™ (clonidine hydrochloride) oral ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果